Eye doses

What are the two major challenges for delivering large eye doses of a drug directly to the eye based on its anatomy and physiology? What (if anything) can be done as a formulator to overcome these challenges? Why is it important that an ophthalmic formulation is isotonic with the fluids in the eye? Why is maintaining a specific pH of the formulation important?